Overview

The Safety of Proctofoam-HC in the Third Trimester of Pregnancy

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the fetal safety of topical application of Proctofoam-HC®, an antihemorrhoidal, in the third trimester of pregnancy.
Details
Lead Sponsor:
The Hospital for Sick Children
Collaborator:
Duchesnay Inc.
Treatments:
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone hemisuccinate
Pramoxine